Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000690	du-aldos	nmol/24h (nmol/24h)	25	30	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hyperaldosteronism

+∞

8.34

1.1

0.0

41.88

—

nmol/24h

—

Hypertension, essential

13.69

6.45

1.1

1.0

29.56

30.00

nmol/24h

—

Hypertensive diseases

12.45

5.74

1.1

1.0

31.35

30.00

nmol/24h

—

Hypertension

12.44

5.74

1.1

1.0

31.35

30.00

nmol/24h

—

Metabolic disorders

5.65

4.50

1.0

1.3

25.39

32.35

nmol/24h

—

Benign neoplasms

5.02

3.03

1.1

1.3

30.22

33.38

nmol/24h

—

Localized swelling, mass and lump of skin and subcutaneous tissue

8.34

2.75

1.4

1.0

15.80

41.67

nmol/24h

—

Contact with and exposure to communicable diseases

8.30

2.74

1.2

1.0

45.60

19.80

nmol/24h

—

Other viral diseases

7.12

2.54

1.2

1.0

22.58

35.54

nmol/24h

—

Nerve, nerve root and plexus disorders

3.77

2.49

1.0

1.3

31.99

27.05

nmol/24h

—

Sleep disorders (combined)

3.69

2.46

1.4

1.1

33.08

27.38

nmol/24h

—

Benign neoplasms

4.95

2.44

1.1

1.4

26.29

31.97

nmol/24h

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

5.24

2.38

1.0

23.97

30.77

nmol/24h

—

Persons with potential health hazards related to communicable diseases

6.20

2.35

1.2

1.0

45.60

24.23

nmol/24h

—

Symptoms and signs involving the skin and subcutaneous tissue

4.10

2.34

1.3

1.1

19.86

32.63

nmol/24h

—

Dorsalgia

3.61

2.12

1.1

1.2

33.86

26.57

nmol/24h

—

Headache

4.18

2.05

1.3

1.1

20.65

34.48

nmol/24h

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

4.08

2.01

1.0

23.97

33.58

nmol/24h

—

Sleep apnoea, including avohilmo

3.24

1.99

1.5

1.1

32.34

28.50

nmol/24h

—

Other headache syndromes

4.17

1.82

1.4

1.0

19.40

36.08

nmol/24h

—

Cystitis

3.29

1.80

1.0

1.2

33.41

29.98

nmol/24h

—

Persons encountering health services for specific procedures and health care

2.91

1.78

1.0

1.3

20.74

33.52

nmol/24h

—

Cardiac arrhythmias

3.60

1.76

1.0

1.1

24.33

36.53

nmol/24h

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.07

1.73

1.0

1.3

19.99

33.30

nmol/24h

—

Medical abortion

3.62

1.70

1.2

1.1

17.47

32.77

nmol/24h

—

Exclusions for E4_PCOS_CONSORTIUM

3.42

1.67

1.0

1.1

24.65

28.44

nmol/24h

—

Sleep apnoea

2.97

1.66

1.6

1.1

23.53

31.94

nmol/24h

—

Leiomyoma of uterus

4.02

1.61

1.0

1.1

21.78

21.83

nmol/24h

—

General examination and investigation of persons without complaint and reported diagnosis

3.80

1.53

1.2

1.1

37.98

41.29

nmol/24h

—

Lower back pain or/and sciatica

2.70

1.51

1.1

1.2

37.43

26.32

nmol/24h

—

Other intervertebral disc disorders

3.06

1.50

1.3

1.2

36.33

26.57

nmol/24h

—

Leiomyoma of uterus

3.55

1.47

1.0

1.1

21.78

20.98

nmol/24h

—

Autoimmune diseases

2.75

1.47

1.1

1.3

23.26

34.77

nmol/24h

—

Lumbar disc prolapse

3.31

1.47

1.4

1.3

37.60

26.57

nmol/24h

—

Used for control exclusion in common control thyroid runs

2.73

1.45

1.1

1.3

23.26

34.77

nmol/24h

—

Disorders of lens

2.91

1.44

1.2

33.32

27.00

nmol/24h

—

Disorders of eyelid, lacrimal system and orbit

2.77

1.41

1.0

1.2

25.98

30.40

nmol/24h

—

Care involving use of rehabilitation procedures

2.97

1.36

1.0

1.3

22.18

32.99

nmol/24h

—

Gastro-oesophageal reflux disease

2.95

1.34

1.0

1.2

18.78

32.99

nmol/24h

—

Dental pulpitis 2

3.20

1.32

1.0

1.1

42.60

24.10

nmol/24h

—

Dental pulpitis 2, only avohilmo

3.20

1.32

1.0

1.1

42.60

24.10

nmol/24h

—

Hypothyroidism, strict autoimmune

3.01

1.31

1.0

1.2

15.54

34.82

nmol/24h

—

Polycystic ovarian syndrome, consortium definition

3.02

1.29

1.2

1.0

15.98

31.18

nmol/24h

—

Renal tubulo-interstitial diseases

2.56

1.29

1.0

1.2

25.33

30.09

nmol/24h

—

Other disorders of urethra and urinary system

2.88

1.28

1.2

23.40

29.98

nmol/24h

—

Other joint disorders

2.66

1.28

1.3

1.2

28.30

36.75

nmol/24h

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.57

1.24

1.2

1.3

31.17

34.77

nmol/24h

—

Disorders of lipoprotein metabolism and other lipidaemias

2.86

1.24

1.0

1.3

17.98

32.35

nmol/24h

—

Autoimmune diseases excluding thyroid diseases

2.56

1.24

1.2

1.3

31.17

34.77

nmol/24h

—

Senile cataract

2.82

1.22

1.2

1.3

35.78

20.73

nmol/24h

—

Dizziness and giddiness

2.71

1.22

1.0

1.3

16.58

32.92

nmol/24h

—

Acute appendicitis

2.62

1.20

1.4

1.1

32.58

29.38

nmol/24h

—

Dental operations

2.85

1.20

1.0

1.2

25.80

28.53

nmol/24h

—

Hernia

0.00

1.19

0.0

1.2

—

29.38

—

Dental operations, only avohilmo

2.85

1.19

1.0

1.2

25.80

28.53

nmol/24h

—

Depression or dysthymia

2.80

1.19

1.2

1.1

34.98

34.78

nmol/24h

—

Dental caries 1, only avohilmo

2.84

1.19

1.0

1.1

42.60

27.76

nmol/24h

—

Dental caries, including avohilmo

2.84

1.19

1.0

1.1

42.60

27.76

nmol/24h

—

Dental caries 1

2.84

1.19

1.0

1.1

42.60

27.76

nmol/24h

—

Use of hypnotics and sedatives

2.53

1.17

1.0

1.3

17.27

36.74

nmol/24h

—

Appendicitis, broad definition

2.54

1.16

1.4

1.1

32.58

29.38

nmol/24h

—

Diseases of appendix

2.53

1.15

1.4

1.1

32.58

29.38

nmol/24h

—

Ischemic heart diseases

2.61

1.13

1.0

1.3

26.78

25.17

nmol/24h

—

Ischaemic heart disease, wide definition

2.61

1.13

1.0

1.3

26.78

25.17

nmol/24h

—

Mood disorders, excluding more controls

2.43

0.98

1.3

1.1

35.83

31.25

nmol/24h

—

Exposure to unspecified factor

0.00

0.97

0.0

1.2

—

29.43

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2.41

0.97

1.0

1.2

16.12

33.53

nmol/24h

—

Anxiety disorders

2.36

0.96

1.2

28.98

30.82

nmol/24h

—

Disorders of the thyroid gland

2.31

0.95

1.0

1.2

13.95

34.76

nmol/24h

—

Mood [affective] disorders

2.19

0.92

1.3

1.2

35.83

27.76

nmol/24h

—

Mood disorders

2.19

0.92

1.3

1.2

35.83

27.76

nmol/24h

—

Other heart diseases, wide

2.19

0.92

1.0

1.2

24.33

32.63

nmol/24h

—

Artrosis, including avohilmo

2.19

0.91

1.2

27.97

25.86

nmol/24h

—

Psychiatric diseases

2.00

0.84

1.3

1.1

30.15

31.25

nmol/24h

—

Any mental disorder

2.00

0.84

1.3

1.1

30.15

31.25

nmol/24h

—

Dental caries 1 and operation codes

2.33

0.79

1.0

1.2

42.60

27.80

nmol/24h

—

Tramadol

2.30

0.78

1.4

1.1

43.00

27.05

nmol/24h

—

Abnormalities of breathing

2.29

0.78

1.2

35.18

33.22

nmol/24h

—

Anxiety disorders, excluding more controls

2.21

0.77

1.2

1.1

30.58

31.25

nmol/24h

—

Episodal and paroxysmal disorders

2.13

0.75

1.2

1.0

20.54

36.08

nmol/24h

—

Dorsopathies

2.13

0.74

1.0

1.3

44.40

26.57

nmol/24h

—

Arthropathies

2.12

0.74

1.0

1.2

14.56

36.75

nmol/24h

—

Hypothyroidism, other/unspecified

2.06

0.73

1.0

1.2

15.54

35.25

nmol/24h

—

Other disorders of ear

1.96

0.71

1.2

26.78

29.40

nmol/24h

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.94

0.70

1.0

1.2

15.54

33.53

nmol/24h

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.89

0.69

1.0

1.2

22.40

30.62

nmol/24h

—

Neurotic, stress-related and somatoform disorders

1.87

0.68

1.2

30.98

30.20

nmol/24h

—

Other diseases of urinary system

1.88

0.68

1.0

1.2

28.38

29.72

nmol/24h

—

Any event in cancer register

1.85

0.67

1.0

1.2

22.40

31.42

nmol/24h

—

Other antidepressants

1.86

0.67

1.4

1.1

30.38

31.13

nmol/24h

—

Other soft tissue disorders, not elsewhere classified

1.82

0.66

1.2

1.1

24.40

31.98

nmol/24h

—

Benzodiazepine use

1.78

0.65

1.2

16.38

32.69

nmol/24h

—

General symptoms and signs

1.79

0.64

1.0

1.2

24.18

34.49

nmol/24h

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.74

0.63

1.0

1.2

19.20

30.92

nmol/24h

—

Malignant neoplasm, wide definition for exclusion

1.74

0.63

1.0

1.2

19.20

30.92

nmol/24h

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1.74

0.63

1.0

1.2

19.20

30.92

nmol/24h

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.71

0.62

1.2

27.40

29.30

nmol/24h

—

Dislocation, sprain and strain of joints and ligaments of knee

0.00

0.59

0.0

1.2

—

28.94

—

Diseases of the ear and mastoid process

1.60

0.54

1.2

24.82

30.88

nmol/24h

—

Other diseases of upper respiratory tract

1.74

0.45

1.0

1.3

22.34

29.80

nmol/24h

—

Disorders of gallbladder, biliary tract and pancreas

1.70

0.44

1.2

18.20

31.72

nmol/24h

—

Diseases of oesophagus, stomach and duodenum

1.69

0.44

1.0

1.2

18.98

33.16

nmol/24h

—

Malignant neoplasm

1.65

0.44

1.0

1.2

21.00

29.54

nmol/24h

—

Delivery

0.00

0.43

0.0

1.1

—

30.24

—

Persons encountering health services in circumstances related to reproduction

0.00

0.41

0.0

1.1

—

31.66

—

Inguinal hernia

0.00

0.41

0.0

1.3

—

37.83

—

Primary gonarthrosis, bilateral

0.00

0.41

0.0

1.2

—

25.71

—

Visual disturbances and blindness

0.00

0.41

0.0

1.1

—

29.98

—

Glucosamine medication

0.00

0.41

0.0

1.1

—

24.71

—

Other and unspecified dermatitis

0.00

0.41

0.0

1.1

—

29.73

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.00

0.41

0.0

1.1

—

25.42

—

Allergic conjunctivitis

0.00

0.40

0.0

1.1

—

27.10

—

Gonarthrosis, primary, with knee surgery

0.00

0.40

0.0

1.3

—

25.79

—

Glaucoma

0.00

0.40

0.0

1.2

—

29.62

—

Dermatitis

0.00

0.40

0.0

1.1

—

30.04

—

Symptoms and signs involving the nervous and musculoskeletal systems

0.00

0.40

0.0

1.1

—

29.15

—

Atopic dermatitis

0.00

0.40

0.0

1.1

—

30.61

—

Disorders of synovium and tendon

0.00

0.39

0.0

1.1

—

31.98

—

Acetic acid derivatives and related substances

0.00

0.22

0.0

1.2

—

37.00

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

0.22

0.0

1.2

—

37.00

—

Labour and delivery complicated by fetal stress [distress]

0.00

0.22

0.0

1.0

—

36.83

—

Dementia, including avohilmo

0.00

0.22

0.0

1.1

—

27.57

—

Contraceptive management

0.00

0.22

0.0

1.0

—

36.49

—

Spontaneous abortion

0.00

0.22

0.0

1.1

—

32.24

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

17.74

—

Long labour

0.00

0.21

0.0

1.0

—

34.20

—

Bacterial pneumoniae

0.00

0.21

0.0

1.1

—

39.56

—

Organic, including symptomatic, mental disorders

0.00

0.21

0.0

1.2

—

27.00

—

Bacterial Sepsis

0.00

0.21

0.0

1.1

—

38.50

—

Atopic dermatitis, strict definition with reimbursement

0.00

0.21

0.0

1.0

—

31.78

—

Preterm labour and delivery

0.00

0.21

0.0

1.0

—

28.27

—

Umbilical hernia

0.00

0.21

0.0

1.2

—

37.45

—

Alcohol dependence

0.00

0.21

0.0

1.1

—

38.50

—

Other enthesopathies

0.00

0.21

0.0

1.0

—

32.15

—

Unspecified fall

0.00

0.21

0.0

1.1

—

35.62

—

Other symptoms and signs involving the nervous and musculoskeletal systems

0.00

0.21

0.0

1.0

—

33.14

—

Open wound of head

0.00

0.21

0.0

1.2

—

36.08

—

Other acute lower respiratory infections

0.00

0.21

0.0

1.1

—

33.73

—

Single spontaneous delivery

0.00

0.21

0.0

1.1

—

30.24

—

Delivery, wide proxy

0.00

0.21

0.0

1.1

—

30.24

—

Hernia of abdominal wall

0.00

0.21

0.0

1.2

—

33.22

—

Open wound of wrist and hand

0.00

0.20

0.0

1.2

—

29.22

—

Malignant neoplasm of breast, HER-positive

0.00

0.20

0.0

1.2

—

18.75

—

Medicines for HER+ breast cancer

0.00

0.20

0.0

1.2

—

18.75

—

Visual disturbances

0.00

0.20

0.0

1.1

—

31.05

—

Other respiratory diseases principally affecting the interstitium

0.00

0.0

1.0

—

25.80

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.0

1.0

—

31.00

—

Dementia

0.00

0.0

1.0

—

31.00

—

Later onset COPD

0.00

0.0

1.0

—

32.57

—

Adverse effects, not elsewhere classified

0.00

0.0

1.0

—

37.17

—

ILD, hospital admissions 1, main diag only

0.00

0.0

1.0

—

25.80

—

Acute bronchitis

0.00

0.0

1.0

—

39.00

—

N06DA Anticholinesterases

0.00

0.0

1.0

—

31.00

—

Abnormalities of gait and mobility

0.00

0.0

1.0

—

40.60

—

IBD patients in KELA-register

0.00

0.0

1.0

—

37.17

—

Functional dyspepsia

0.00

0.0

1.0

—

37.67

—

Ventral hernia

0.00

0.0

1.0

—

32.57

—

Non-small cell lung cancer

0.00

0.0

1.0

—

25.80

—

Schizophrenia

0.00

0.0

1.0

—

37.17

—

Fracture of femur

0.00

0.0

1.0

—

37.17

—

Prolonged pregnancy

0.00

0.0

1.0

—

42.60

—

Nasal polyp

0.00

0.0

1.1

—

42.00

—

Other diseases of the respiratory system

0.00

0.0

1.0

—

37.17

—

Visual field defects

0.00

0.0

1.0

—

38.60

—

Inflammatory bowel disease, strict (require KELA)

0.00

0.0

1.0

—

37.17

—

Asthma-related pneumonia

0.00

0.0

1.0

—

40.00

—

Pre-eclampsia or eclampsia

0.00

0.0

1.0

—

28.97

—

Bacterial pneumonia (organism specified)

0.00

0.0

1.0

—

40.25

—

Non-allergic asthma

0.00

0.0

1.0

—

25.80

—

L02BG Aromatase inhibitors

0.00

0.0

1.1

—

16.74

—

Operations 2 for CAVS

0.00

0.0

1.0

—

31.00

—

Sulfonylureas

0.00

0.0

1.0

—

36.33

—

Malignant melanoma

0.00

0.0

1.0

—

25.80

—

Unspecific neurodegenerative disorder

0.00

0.0

1.0

—

31.00

—

Use of anticholinesterases

0.00

0.0

1.0

—

31.00

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.0

1.0

—

32.57

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.0

1.0

—

40.60

—

malignant neoplasm of male genital organs

0.00

0.0

1.3

—

38.17

—

Nontraumatic intracranial haemmorrhage

0.00

0.0

1.0

—

25.80

—

Other diseases of the digestive system

0.00

0.0

1.1

—

39.56

—

Other respiratory disorders and diseases

0.00

0.0

1.0

—

37.17

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.00

0.0

1.0

—

22.22

—

Parkinson's disease

0.00

0.0

1.0

—

25.80

—

Tinnitus

0.00

0.0

1.0

—

45.67

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.0

1.0

—

38.60

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.0

1.0

—

42.60

—

Thyrotoxicosis

0.00

0.0

1.0

—

30.35

—

Fracture of foot, except ankle

0.00

0.0

1.0

—

37.17

—

Suggestive for eosinophilic asthma

0.00

0.0

1.0

—

25.80

—

Internal derangement of knee

0.00

0.0

1.1

—

42.00

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.0

1.0

—

25.80

—

Heart failure and coronary heart disease

0.00

0.0

1.0

—

36.33

—

Peritonsillar abscess

0.00

0.0

1.0

—

36.00

—

Benign paroxysmal vertigo

0.00

0.0

1.1

—

33.00

—

Graves disease, strict definition

0.00

0.0

1.0

—

37.17

—

Allergic rhinitis

0.00

0.0

1.0

—

32.09

—

Mycoses

0.00

0.0

1.0

—

37.17

—

Glaucoma suspect

0.00

0.0

1.1

—

36.00

—

Benign neoplasm of meninges

0.00

0.0

1.0

—

25.80

—

Coeliac disease

0.00

0.0

1.0

—

37.17

—

Fibroblastic disorders

0.00

0.0

1.0

—

35.60

—

Paralytic ileus and intestinal obstruction

0.00

0.0

1.0

—

31.00

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.0

1.0

—

38.60

—

Hypertrophy of breast

0.00

0.0

1.0

—

34.47

—

Pre-eclampsia

0.00

0.0

1.0

—

28.97

—

Allergic contact dermatitis

0.00

0.0

1.0

—

37.17

—

Atrophic disorders of skin

0.00

0.0

1.0

—

40.60

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

0.0

1.0

—

40.60

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.0

1.1

—

36.00

—

Acute suppurative otitis media

0.00

0.0

1.2

—

36.97

—

Psoriasis vulgaris

0.00

0.0

1.0

—

38.60

—

Coronary artery bypass grafting

0.00

0.0

1.2

—

33.80

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

0.0

1.0

—

37.17

—

Colonic or urogenital fistula

0.00

0.0

1.0

—

31.00

—

Calcific aortic valvular stenosis, operated

0.00

0.0

1.0

—

31.00

—

Any dementia, excluding more controls

0.00

0.0

1.0

—

31.00

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.0

1.0

—

25.80

—

Soft tissue disorders related to use, overuse and pressure

0.00

0.0

1.0

—

35.24

—

Implicit bacterial Sepsis

0.00

0.0

1.1

—

39.56

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.0

1.0

—

37.17

—

Viral Sepsis

0.00

0.0

1.0

—

37.17

—

Gastric ulcer

0.00

0.0

1.0

—

35.20

—

Implicit viral Sepsis

0.00

0.0

1.0

—

37.17

—

Ganglion

0.00

0.0

1.0

—

31.09

—

Asthma, hospital admissions 3, pneumonia

0.00

0.0

1.0

—

40.00

—

Asthma-related pneumonia or sepsis

0.00

0.0

1.0

—

40.00

—

Recurring oral aphthae, including avohilmo

0.00

0.0

1.0

—

37.17

—

Malignant neoplasm of prostate

0.00

0.0

1.3

—

38.17

—

Personality disorders, excluding more controls

0.00

0.0

1.0

—

26.35

—

Benign neoplasm of mouth and pharynx

0.00

0.0

1.0

—

25.80

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.0

1.0

—

37.17

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

25.80

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.0

1.0

—

32.57

—

Noninfectious colitis NAS

0.00

0.0

1.0

—

37.17

—

Combinations of oral blood glucose lowering drugs

0.00

0.0

1.0

—

35.29

—

TMD related operations

0.00

0.0

1.0

—

37.17

—

Ethmoidectomy

0.00

0.0

1.0

—

37.17

—

Alzheimer disease, including avohilmo

0.00

0.0

1.0

—

31.00

—

Degenerative diseases of the nervous system

0.00

0.0

1.0

—

25.80

—

Gout, FINNGEN

0.00

0.0

1.2

—

37.00

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.0

—

30.35

—

Disorders of adult personality and behaviour

0.00

0.0

1.0

—

30.35

—

Specific personality disorders

0.00

0.0

1.0

—

32.83

—

FESS (DNB20)

0.00

0.0

1.0

—

37.17

—

Pulmonary heart disease

0.00

0.0

1.0

—

31.00

—

Polyneuropathies and other disorders of the peripheral nervous system

0.00

0.0

1.0

—

31.00

—

Parkinson's disease, including avohilmo

0.00

0.0

1.0

—

25.80

—

Calcific aortic valvular stenosis

0.00

0.0

1.0

—

31.00

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.0

1.0

—

31.00

—

Disorders of refraction and accommodation

0.00

0.0

1.0

—

32.83

—

Primary open-angle glaucoma

0.00

0.0

1.0

—

31.00

—

Myocardial infarction, unclassifiable

0.00

0.0

1.0

—

33.20

—

Myocardial infarction, without ST-elevation

0.00

0.0

1.1

—

32.75

—

Intestinal adhesions without obstruction

0.00

0.0

1.0

—

25.80

—

Valvular operations

0.00

0.0

1.0

—

35.60

—

Bacterial intestinal infections, IBD co-morbidities

0.00

0.0

1.0

—

37.17

—

Pulmonary heart disease, diseases of pulmonary circulation

0.00

0.0

1.0

—

31.00

—

Insulin, fast-acting or short human

0.00

0.0

1.0

—

39.00

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.0

1.0

—

38.60

—

Insulin, fast-acting

0.00

0.0

1.0

—

39.00

—

Bacterial pneumonia, not elsewhere classified

0.00

0.0

1.0

—

40.25

—

Dental caries

0.00

0.0

1.1

—

42.25

—

ILD, hospital admissions

0.00

0.0

1.0

—

25.80

—

Any dementia

0.00

0.0

1.0

—

31.00

—

Other diseases of intestine

0.00

0.0

1.0

—

25.80

—

Other or unspecified ileus, impaction or obstruction

0.00

0.0

1.0

—

31.00

—

GI-bleeding

0.00

0.0

1.1

—

39.56

—

Intestinal stricture

0.00

0.0

1.0

—

31.00

—

Inflammatory bowel disease

0.00

0.0

1.0

—

32.83

—

Ménière disease

0.00

0.0

1.0

—

25.80

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.0

1.0

—

38.60

—

Pruritus

0.00

0.0

1.0

—

37.17

—

Acute renal failure

0.00

0.0

1.0

—

31.00

—

Diseases of external ear

0.00

0.0

1.0

—

40.00

—

Direct fill therapy

0.00

0.0

1.0

—

40.60

—

Maternal care for other conditions predominantly related to pregnancy

0.00

0.0

1.0

—

42.60

—

Other disorders of patella

0.00

0.0

1.0

—

49.00

—

Other disorders of kidney and ureter

0.00

0.0

1.0

—

25.80

—

Thyroiditis

0.00

0.0

1.0

—

25.80

—

Hypertrophy of breast in women and men

0.00

0.0

1.0

—

34.48

—

Chronic periapical parodontitis

0.00

0.0

1.1

—

46.43

—

Acute pancreatitis (for exclusion)

0.00

0.0

1.0

—

25.80

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.0

1.0

—

36.83

—

Tumor necrosis factor alpha inhibitors

0.00

0.0

1.0

—

43.40

—

Medical treatment for female infertility

0.00

0.0

1.0

—

27.30

—

Pregnancy, childbirth and the puerperium

0.00

0.0

1.0

—

37.98

—

Preparation and fitting of bite rail to mouth

0.00

0.0

1.0

—

38.60

—

L04AA Selective immunosuppressants

0.00

0.0

1.0

—

37.17

—

Fenamates

0.00

0.0

1.2

—

37.00

—

Pacemaker

0.00

0.0

1.0

—

32.57

—

Peripheral arterial reconstruction

0.00

0.0

1.0

—

33.20

—

Use of pramipexole

0.00

0.0

1.0

—

25.80

—

Other skin changes

0.00

0.0

1.0

—

38.60

—

Pain associated with micturition

0.00

0.0

1.0

—

37.17

—

Polyuria

0.00

0.0

1.0

—

25.80

—

Abnormal involuntary movements

0.00

0.0

1.0

—

37.17

—

Rash and other nonspecific skin eruption

0.00

0.0

1.0

—

38.60

—

Other symptoms and signs involving the digestive system and abdomen

0.00

0.0

1.0

—

42.76

—

Pain, not elsewhere classified

0.00

0.0

1.0

—

35.13

—

Abnormal serum enzyme levels

0.00

0.0

1.3

—

34.14

—

Superficial injury of lower leg

0.00

0.0

1.0

—

32.00

—

Superficial injury of head

0.00

0.0

1.0

—

37.17

—

Superficial injury of thorax

0.00

0.0

1.0

—

38.60

—

Unspecified urinary incontinence

0.00

0.0

1.0

—

25.80

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.0

1.0

—

25.80

—

Dentinal caries

0.00

0.0

1.1

—

46.43

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.00

0.0

1.0

—

38.67

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.0

1.1

—

33.00

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.00

0.0

1.1

—

38.11

—

Open wound of lower leg

0.00

0.0

1.0

—

32.00

—

Type 1 diabetes, wide definition

0.00

0.0

1.0

—

42.60

—

Thyroiditis, ILD-related definition

0.00

0.0

1.0

—

38.60

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.0

1.0

—

42.60

—

Poisoning by drugs, medicaments and biological substances

0.00

0.0

1.0

—

32.83

—

Poisoning by medicine

0.00

0.0

1.0

—

37.17

—

Sub-endpoint used in defining T1D endpoints

0.00

0.0

1.0

—

40.00

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.0

1.0

—

38.60

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

0.0

1.0

—

38.60

—

Misadventures to patients during surgical and medical care

0.00

0.0

1.0

—

38.60

—

Other fall from one level to another

0.00

0.0

1.0

—

37.17

—

Weight loss

0.00

0.0

1.0

—

40.60

—

Pedal cyclist injured in transport accident

0.00

0.0

1.0

—

37.17

—

Presence of cardiac and vascular implants and grafts

0.00

0.0

1.3

—

34.43

—

Family history of malignant neoplasm

0.00

0.0

1.0

—

43.40

—

Persons encountering health services in other circumstances

0.00

0.0

1.0

—

29.31

—

0.00

0.0

1.0

—

25.80

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

35.60

—

Speech therapy

0.00

0.0

1.0

—

37.17

—

Parkinson's disease, excluding more controls

0.00

0.0

1.0

—

35.60

—

Otitis externa

0.00

0.0

1.0

—

37.17

—

Ulcerative colitis

0.00

0.0

1.0

—

37.17

—

Other and unspecified visual disturbances

0.00

0.0

1.0

—

37.17

—

Other and unspecified effects of external causes

0.00

0.0

1.0

—

32.83

—

Glomerular diseases

0.00

0.0

1.0

—

40.60

—

Personality disorders

0.00

0.0

1.0

—

32.83

—

DVT of lower extremities and pulmonary embolism

0.00

0.0

1.1

—

29.50

—

Diplopia

0.00

0.0

1.0

—

37.17

—

Somatoform disorder

0.00

0.0

1.0

—

25.80

—

Other interstitial pulmonary diseases

0.00

0.0

1.0

—

25.80

—

Spondyloarthritis

0.00

0.0

1.0

—

38.60

—

Interstitial lung disease

0.00

0.0

1.0

—

25.80

—

Other bacterial intestinal infections

0.00

0.0

1.0

—

42.60

—

Other spirochaetal diseases

0.00

0.0

1.0

—

37.17

—

Fracture of skull and facial bones

0.00

0.0

1.0

—

36.00

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

0.00

0.0

1.0

—

32.35

—

Type 1 diabetes

0.00

0.0

1.0

—

42.71

—

Fissure and fistula of anal and rectal regions

0.00

0.0

1.0

—

31.00

—

Fall on and from stairs and steps

0.00

0.0

1.0

—

37.17

—

Myeloproliferative diseases

0.00

0.0

1.0

—

25.80

—

Vasomotor and allergic rhinitis

0.00

0.0

1.0

—

31.63

—

Superficial injury of wrist and hand

0.00

0.0

1.0

—

25.80

—

Gout, idiopatic and unspecified

0.00

0.0

1.0

—

32.57

—

Atopic dermatitis, strict definition

0.00

0.0

1.0

—

32.09

—

Parkinson's disease, strict definition

0.00

0.0

1.0

—

25.80

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

0.00

0.0

1.1

—

27.87

—

Other disorders of amniotic fluid and membranes

0.00

0.0

1.0

—

42.60

—

Crohn disease

0.00

0.0

1.0

—

38.60

—

Aortic aneurysm

0.00

0.0

1.0

—

39.60

—

Lyme disease

0.00

0.0

1.0

—

37.17

—

Transient global amnesia

0.00

0.0

1.0

—

25.80

—

Palmar fascial fibromatosis [Dupuytren]

0.00

0.0

1.0

—

35.60

—

Biological medication for rheuma

0.00

0.0

1.0

—

43.40

—

Otosclerosis

0.00

0.0

1.0

—

25.80

—

Other abnormal products of conception

0.00

0.0

1.0

—

39.98

—

Vestibular neuronitis

0.00

0.0

1.0

—

25.80

—

Other diseases of liver

0.00

0.0

1.0

—

25.80

—

Covid-19 suspected case

0.00

0.0

1.0

—

22.63

—

Normotensive glaucoma

0.00

0.0

1.0

—

25.80

—

Ulcerative colitis, NAS

0.00

0.0

1.0

—

38.60

—

Myalgia

0.00

0.0

1.0

—

34.11

—

Gastroduodenal ulcer

0.00

0.0

1.1

—

36.00

—

Endometriosis ASRM stages 1,2

0.00

0.0

1.0

—

28.97

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.0

1.0

—

37.17

—

Mucosal proctocolitis

0.00

0.0

1.0

—

38.60

—

Other and unspecified polyneuropathies, also in other diseases

0.00

0.0

1.0

—

31.00

—

Pulmonary embolism

0.00

0.0

1.0

—

31.00

—

Bronchiectasis

0.00

0.0

1.0

—

25.80

—

Viral and other specified intestinal infections

0.00

0.0

1.2

—

42.33

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

1.0

—

25.80

—

Acute alcohol intoxication

0.00

0.0

1.1

—

39.56

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.0

1.0

—

37.17

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.0

1.0

—

25.80

—

Benign neoplasm: Cerebral meninges

0.00

0.0

1.0

—

25.80

—

Conduction disorders

0.00

0.0

1.0

—

45.33

—

Other degenerative diseases of the nervous system

0.00

0.0

1.0

—

35.60

—

Aneurysms, operations, SAH

0.00

0.0

1.0

—

25.80

—

Premature rupture of membranes

0.00

0.0

1.0

—

42.60

—

Cellulitis

0.00

0.0

1.0

—

37.17

—

Infective dermatitis

0.00

0.0

1.0

—

37.17

—

Substance use, excluding alcohol

0.00

0.0

1.0

—

37.17

—

Nonsuppurative otitis media

0.00

0.0

1.0

—

37.17

—

Fracture of lumbar spine and pelvis

0.00

0.0

1.0

—

37.17

—

Retention of urine

0.00

0.0

1.1

—

36.71

—

Endometriosis ASRM stages 3,4

0.00

0.0

1.0

—

20.97

—

Chalazion

0.00

0.0

1.0

—

40.60

—

Suicide or other Intentional self-harm

0.00

0.0

1.0

—

32.83

—

Diaphragmatic hernia

0.00

0.0

1.2

—

30.00

—

Restless leg syndrome

0.00

0.0

1.0

—

37.17

—

Wet age-related macular degeneration

0.00

0.0

1.0

—

25.80

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

25.80

—

Benign neoplasm: Caecum

0.00

0.0

1.0

—

25.80

—

Primary open-angle glaucoma, strict

0.00

0.0

1.0

—

31.00

—

Benign neoplasm: Sigmoid colon

0.00

0.0

1.0

—

25.80

—

Interstitial lung disease endpoints

0.00

0.0

1.0

—

25.80

—

Subjective visual disturbances

0.00

0.0

1.0

—

37.17

—

Candidiasis

0.00

0.0

1.0

—

37.17

—

Sicca syndrome [Sjögren]

0.00

0.0

1.0

—

25.80

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

1.0

—

18.84

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aldosterone [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS